Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma
Status:
Completed
Trial end date:
2020-01-07
Target enrollment:
Participant gender:
Summary
The aim of the project is to study the persistence of inflammation after addition of an
interleukin-5 (IL-5) blocker in severe eosinophilic asthma as a study of untreated pathways
in these patients.